Yale School of Medicine: Integrating tobacco treatment in HIV care

Back to the "HIV and Co-Infections News" list

Yale School of Medicine interview

Modern HIV treatment is one of medicine’s great success stories. With today’s therapies, many people living with HIV can expect long, full lives. But as patients age, a new reality has emerged: The biggest threats to their health are often the same ones facing the general population — heart disease, cancer, and chronic lung conditions. For many, smoking is a major contributor to those risks. Yet tobacco use can be overshadowed by other urgent medical and social concerns.

E. Jennifer Edelman, MD, MHS, professor of medicine (general medicine) at Yale School of Medicine, has spent years studying the intersection of HIV and substance use. In her latest study she tested an adaptive, team-based strategy to better integrate tobacco treatment into HIV clinics. The findings were published in JAMA Network Open.

In an interview, Edelman discusses why smoking must become a higher priority in HIV care — and how more flexible, team-based strategies can help patients live longer, healthier lives.

Read the full interview here.

 

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.